Obesity and cardiovascular disease: an ESC clinical consensus statement

被引:8
作者
Koskinas, Konstantinos C. [1 ]
Van Craenenbroeck, Emeline M. [2 ,3 ]
Antoniades, Charalambos [4 ]
Blueher, Matthias [5 ,6 ]
Gorter, Thomas M. [7 ]
Hanssen, Henner [8 ]
Marx, Nikolaus [9 ]
McDonagh, Theresa A. [10 ,11 ]
Mingrone, Geltrude [12 ,13 ,14 ]
Rosengren, Annika [15 ,16 ]
Prescott, Eva B. [17 ]
机构
[1] Univ Bern, Bern Univ Hosp, Dept Cardiol, INSELSPITAL, Freiburgstrasse 18, CH-3010 Bern, Switzerland
[2] Antwerp Univ Hosp, Dept Cardiol, Drie Eikenstr 655, B-2650 Antwerp, Belgium
[3] Univ Antwerp, Res Grp Cardiovasc Dis, GENCOR, Antwerp, Belgium
[4] Univ Oxford, Acute Multidisciplinary Imaging & Intervent Ctr, Radcliffe Dept Med, Oxford, England
[5] Univ Leipzig, Helmholtz Zentrum Munchen, Leipzig, Germany
[6] Univ Hosp Leipzig, Leipzig, Germany
[7] Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands
[8] Univ Basel, Dept Sport Exercise & Hlth, Basel, Switzerland
[9] Rhein Westfal TH Aachen, Dept Internal Med Cardiol 1, Aachen, Germany
[10] Kings Coll Hosp London, Cardiol Dept, London, England
[11] Kings Coll London, London, England
[12] Kings Coll London, Cardiovasc & Metab Med & Sci, London, England
[13] Fdn Policlin Univ A Gemelli, Dept Med & Surg Sci, Rome, Italy
[14] Catholic Univ, Rome, Italy
[15] Univ Gothenburg, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden
[16] Sahlgrens Univ Hosp, Vastra Gotaland Reg, Gothenburg, Sweden
[17] Univ Copenhagen, Bispebjerg Frederiksberg Hosp, Bispebjerg Bakke 23, DK-2400 Copenhagen, Denmark
关键词
Anti-obesity drugs; Adipose tissue; Arrhythmia; Atherosclerosis; Bariatric interventions; Cardiovascular disease; Lifestyle interventions; Heart failure; Cardiovascular risk factors; Venous Thromboembolism; Valvular heart disease; BODY-MASS INDEX; EPICARDIAL ADIPOSE-TISSUE; LIFE-STYLE INTERVENTION; PERCUTANEOUS CORONARY INTERVENTION; ALL-CAUSE MORTALITY; INDUCED WEIGHT-LOSS; DOSE-RESPONSE METAANALYSIS; REDUCED EJECTION FRACTION; OBSTRUCTIVE SLEEP-APNEA; SUDDEN CARDIAC DEATH;
D O I
10.1093/eurjpc/zwae279
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The global prevalence of obesity has more than doubled over the past four decades, currently affecting more than a billion individuals. Beyond its recognition as a high-risk condition that is causally linked to many chronic illnesses, obesity has been declared a disease per se that results in impaired quality of life and reduced life expectancy. Notably, two-thirds of obesity-related excess mortality is attributable to cardiovascular disease. Despite the increasingly appreciated link between obesity and a broad range of cardiovascular disease manifestations including atherosclerotic disease, heart failure, thromboembolic disease, arrhythmias, and sudden cardiac death, obesity has been underrecognized and sub-optimally addressed compared with other modifiable cardiovascular risk factors. In the view of major repercussions of the obesity epidemic on public health, attention has focused on population-based and personalized approaches to prevent excess weight gain and maintain a healthy body weight from early childhood and throughout adult life, as well as on comprehensive weight loss interventions for persons with established obesity. This clinical consensus statement by the European Society of Cardiology discusses current evidence on the epidemiology and aetiology of obesity; the interplay between obesity, cardiovascular risk factors and cardiac conditions; the clinical management of patients with cardiac disease and obesity; and weight loss strategies including lifestyle changes, interventional procedures, and anti-obesity medications with particular focus on their impact on cardiometabolic risk and cardiac outcomes. The document aims to raise awareness on obesity as a major risk factor and provide guidance for implementing evidence-based practices for its prevention and optimal management within the context of primary and secondary cardiovascular disease prevention. Graphical Abstract Main causal factors and cardiovascular consequences of obesity. CV, cardiovascular; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction; SCD, sudden cardiac death.
引用
收藏
页码:184 / 220
页数:37
相关论文
共 341 条
  • [31] Obesity and Antiplatelets-Does One Size Fit All?
    Beavers, Craig J.
    Heron, Paula
    Smyth, Susan S.
    Bain, Jonathan A.
    Macaulay, Tracy E.
    [J]. THROMBOSIS RESEARCH, 2015, 136 (04) : 712 - 716
  • [32] Echocardiographic Measures of Cardiac Structure and Function Are Associated with Risk of Atrial Fibrillation in Blacks: The Atherosclerosis Risk in Communities (ARIC) Study
    Bekwelem, Wobo
    Misialek, Jeffrey R.
    Konety, Suma
    Solomon, Scott D.
    Soliman, Elsayed Z.
    Loehr, Laura R.
    Lopez, Faye L.
    Fox, Ervin R.
    Mosley, Thomas H.
    Alonso, Alvaro
    [J]. PLOS ONE, 2014, 9 (10):
  • [33] The Natural Course of Healthy Obesity Over 20 Years
    Bell, Joshua A.
    Hamer, Mark
    Sabia, Severine
    Singh-Manoux, Archana
    Batty, G. David
    Kivimaki, Mika
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (01) : 101 - 102
  • [34] Effect of exercise training on weight loss, body composition changes, and weight maintenance in adults with overweight or obesity: An overview of 12 systematic reviews and 149 studies
    Bellicha, Alic
    van Baak, Marleen A.
    Battista, Francesca
    Beaulieu, Kristine
    Blundell, John E.
    Busetto, Luca
    Carraca, Eliana V.
    Dicker, Dror
    Encantado, Jorge
    Ermolao, Andrea
    Farpour-Lambert, Nathalie
    Pramono, Adriyan
    Woodward, Euan
    Oppert, Jean-Michel
    [J]. OBESITY REVIEWS, 2021, 22
  • [35] Predictors and outcomes of heart failure with mid-range ejection fraction
    Bhambhani, Vijeta
    Kizer, Jorge R.
    Lima, Joao A. C.
    van der Harst, Pim
    Bahrami, Hossein
    Nayor, Matthew
    de Filippi, Christopher R.
    Enserro, Danielle
    Blaha, Michael J.
    Cushman, Mary
    Wang, Thomas J.
    Gansevoort, Ron T.
    Fox, Caroline S.
    Gaggin, Hanna K.
    Kop, Willem J.
    Liu, Kiang
    Vasan, Ramachandran S.
    Psaty, Bruce M.
    Lee, Douglas S.
    Brouwers, Frank P.
    Hillege, Hans L.
    Bartz, Traci M.
    Benjamin, Emelia J.
    Chan, Cheeling
    Allison, Matthew
    Gardin, Julius M.
    Januzzi, James L., Jr.
    Levy, Daniel
    Herrington, David M.
    van Gilst, Wiek H.
    Bertoni, Alain G.
    Larson, Martin G.
    de Boer, Rudolf A.
    Gottdiener, John S.
    Shah, Sanjiv J.
    Ho, Jennifer E.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 (04) : 651 - 659
  • [36] Naltrexone/bupropion for obesity: An investigational combination pharmacotherapy for weight loss
    Billes, Sonja K.
    Sinnayah, Puspha
    Cowley, Michael A.
    [J]. PHARMACOLOGICAL RESEARCH, 2014, 84 : 1 - 11
  • [37] New insights into the treatment of obesity
    Blueher, Matthias
    Aras, Mohini
    Aronne, Louis J.
    Batterham, Rachel L.
    Giorgino, Francesco
    Ji, Linong
    Pietilainen, Kirsi H.
    Schnell, Oliver
    Tonchevska, Elena
    Wilding, John P. H.
    [J]. DIABETES OBESITY & METABOLISM, 2023, 25 (08) : 2058 - 2072
  • [38] Obesity: global epidemiology and pathogenesis
    Blueher, Matthias
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2019, 15 (05) : 288 - 298
  • [39] Impact of anthropometric factors on outcomes in atrial fibrillation patients: analysis on 10 220 patients from the European Society of Cardiology (ESC)-European Heart Rhythm Association (EHRA) EurObservational Research Programme on Atrial Fibrillation (EORP-AF) general long-term registry
    Boriani, Giuseppe
    Vitolo, Marco
    Malavasi, Vincenzo L.
    Proietti, Marco
    Fantecchi, Elisa
    Diemberger, Igor
    Fauchier, Laurent
    Marin, Francisco
    Nabauer, Michael
    Potpara, Tatjana S.
    Dan, Gheorghe Andrei
    Kalarus, Zbigniew
    Tavazzi, Luigi
    Maggioni, Aldo Pietro
    Lane, Deirdre A.
    Lipand, Gregory Y. H.
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 29 (15) : 1967 - 1981
  • [40] Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial
    Boriani, Giuseppe
    Ruff, Christian T.
    Kuder, Julia F.
    Shi, Minggao
    Lanz, Hans J.
    Rutman, Howard
    Mercuri, Michele F.
    Antman, Elliott M.
    Braunwald, Eugene
    Giugliano, Robert P.
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 (19) : 1541 - +